Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Tenon Medical(R) Announces Issuance of Three U.S. Patents
04:05pm, Thursday, 17'th Oct 2024
Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17, 2024 / T
Ryder (R) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Thursday, 17'th Oct 2024
Ryder (R) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Agreement and Plan of Merger
08:00am, Wednesday, 16'th Oct 2024
CLEVELAND, OH / ACCESSWIRE / October 16, 2024 / Mace Security International, Inc. (OTCQB:MACE) ("Mace") today, following an extensive strategic alternatives process, announced that Mace and W Electric
Ryder Reaches 52-Week High: What's Supporting the Stock?
01:50pm, Monday, 14'th Oct 2024
R stock appreciates more than 30% in the past 6 months on multiple tailwinds.
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
04:41pm, Thursday, 10'th Oct 2024
Northvale, New Jersey--(Newsfile Corp. - October 10, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Ryder Declares Quarterly Cash Dividend
04:30pm, Wednesday, 09'th Oct 2024
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--The Board of Directors of Ryder System, Inc. (NYSE: R) declared a regular quarterly cash dividend of $0.81 per share of common stock to be paid on December 2
Theralase(R) Provides Update on Bladder Cancer Clinical Study
07:00am, Monday, 07'th Oct 2024
TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a
Stock Picks From Seeking Alpha's September 2024 New Analysts
08:00am, Friday, 04'th Oct 2024
In September, thirty new analysts joined Seeking Alpha, offering diverse stock picks and insights, from Strong Buy to Strong Sell ratings. Highlighted picks include InMode Ltd., Intel Corporation, and
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / Octob
Ryder Releases Corporate Sustainability Report and CDP Climate Change Response
06:55am, Tuesday, 01'st Oct 2024
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R), a leader in supply chain, dedicated transportation, and fleet management solutions, has released the latest edition of the Ryder Corporate Sustain
Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces 2Q24 Financial Results
04:30pm, Monday, 30'th Sep 2024
CLEVELAND, OH / ACCESSWIRE / September 30, 2024 / Mace Security International (OTCQB:MACE) today announced its second quarter 2024 financial results for the period ended June 30, 2024. Second Quarter
Ryder Systems: Riding The Long-Term Value Chain For Shareholders
10:22am, Sunday, 29'th Sep 2024
Ryder's share price is poised for growth, driven by the expanding service segments, particularly Supply Chain Solutions (SCS) and Dedicated Transportation Solutions (DTS). The service revenue segment
Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Additional Unsecured Subordinated Funding
08:00am, Thursday, 26'th Sep 2024
CLEVELAND, OH / ACCESSWIRE / September 26, 2024 / Mace Security International (OTCQB:MACE) today announced that the Company's Board of Directors approved on September 20, 2024 a $40,000 unsecured subo
Ryder E-commerce Study Reveals In-Store Shopping Sentiment Up 21%
06:55am, Wednesday, 25'th Sep 2024
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder E-commerce study reveals consumers want blend of physical presence and digital convenience, underscoring importance of omnichannel strategy.
Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options
05:00pm, Tuesday, 24'th Sep 2024
TORONTO, ON / ACCESSWIRE / September 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the researc
